As the discussion of the use of cannabis-derived and -related products in veterinary medicine continues to evolve, the AVMA is providing an update for practitioners regarding the legal and regulatory framework surrounding such use.
The information included in the attached document is not specific to the legal or regulatory status of products of any particular company. Rather, it reflects our understanding of the current status of this class of products based on information provided by federal agencies.
Please feel free to share this information and be in touch if you have any questions or concerns.
